Emerging drugs in phase 2/3 and selected phase 1/2 cellular-therapy trials: a glimpse into the future of systemic sclerosis treatment

Annals of the Rheumatic Diseases · Elsevier

Аннотация

Publication date: Available online 23 October 2026 Source: Annals of the Rheumatic Diseases Author(s): Eisha Naveed, Alain Lescoat, Marco Matucci-Cerinic, Masataka Kuwana, Christopher P. Denton, Yannick Allanore, John D. Pauling, Francesco Del Galdo, Zsuzsanna McMahan, Jorg H.W. Distler, Janet Pope, Oliver Distler, Shervin Assassi, Robert Spiera, Lorinda Chung, Laura Cooney, Pei-Suen Tsou, John Varga, Dinesh Khanna

Читать у издателя →

Похожие статьи